Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Montesi (Boston, United States of America). Non-invasive molecular imaging of pulmonary fibrosis. International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease

Member's Comments

No comment yet.

Related content which might interest you: Combining physiology and imaging in the diagnosis of pulmonary hypertension Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines Year: 2019 Gadofosveset-enhanced lung magnetic resonance imaging to detect ongoing vascular leak in pulmonary fibrosis Source: Eur Respir J, 51 (5) 1800171; 10.1183/13993003.00171-2018 Year: 2018 Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging Source: International Congress 2015 – New insights into IIPs Year: 2015 Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Multiphotonics for fibrosis imaging Source: Annual Congress 2009 - WS1 - New imaging methods for the researcher: believe what you see! Year: 2009 Echocardiographic imaging in pulmonary hypertension Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension Source: Eur Respir J 2009; 33: 1454-1466 Year: 2009 Novel imaging biomarkers for assessment of lung fibrosis and inflammation Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Novel magnetic resonance technique for functional imaging of cystic fibrosis lung disease Source: Eur Respir J, 50 (6) 1701464; 10.1183/13993003.01464-2017 Year: 2017 Magnetic resonance in pulmonary arterial hypertension: a noninvasive alternative in the assessment of right ventricular function Source: Eur Respir J 2002; 20: Suppl. 38, 4s Year: 2002 Oxygen-enhanced MRI of the lung in the assessment of chronic obstructive pulmonary disease Source: Annual Congress 2006 - New modalities and application in imaging of the chest Year: 2006 Quantitative lung T1 mapping and oxygen enhanced MRI in IPF Source: International Congress 2014 – The MRI modality becomes clinically mature: lung MRI Year: 2014 Right ventricular interaction in pulmonary arterial hypertension Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Noninvasive pulmonary vascular imaging by MR Source: Annual Congress 2005 - PG1 - Basics in chest imaging: pulmonary vasculature Year: 2005 Changes in magnetic resonance imaging scores and ventilation inhomogeneity in children with cystic fibrosis pulmonary exacerbations Source: Eur Respir J, 50 (2) 1700244; 10.1183/13993003.00244-2017 Year: 2017 Cardiac magnetic resonance imaging versus echocardiography for assessment of cardiac involvement in pulmonary sarcoidosis Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging Year: 2012 Comet tail artifact: A transthoracic chest ultrasound sign useful in assessment of interstitial lung diseases Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Noninvasive estimation of PVR using contrast enhanced MRI in patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging Source: Eur Respir J, 50 (1) 1601437; 10.1183/13993003.01437-2016 Year: 2017 Novel evaluation of pulmonary hypertension with chronic lung disease by perfusion SPECT/CT Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019